Search Results 1321-1330 of 19433 for Hemoglobin

1. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

   - ELIGIBILITY CRITERIA (STEP 1): Hemoglobin >= 9 g/dL - ELIGIBILITY CRITERIA (STEP 1): Creatinine clearance (CrCl) >= 30 mL/min - ELIGIBILITY CRITERIA (STEP ...

2. A Safety Study of SGN-LIV1A in Breast Cancer Patients - Mayo Clinic

   hemoglobin (Hgb) ≥.0 g/dL;; serum bilirubin ≤.5x upper limit of normal (ULN);; serum creatinine ≤.5x ULN;; alanine aminotransferase (ALT) and aspartate ...

3. Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG - Mayo Clinic

   Hemoglobin ≥8.0 g/dL. Subjects receiving therapeutic erythropoietin preparations (i.e., epoetin alfa, darbepoetin alfa) are eligible to enroll. Absolute ...

4. Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency - Mayo Clinic

   Hemoglobin > 9.0 g/dL and < 13.5 g/dL (females) or <15.0 g/dL (males) within 28 days of randomization;; Serum ferritin < 100 ng/mL or 100 to 300 ng/mL with ...

5. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

   Patients must have hemoglobin levels of > 9g/dL;; Patient must have a platelet count of > 100,000/mm3;; Patient's ANC level must be > 1500/mm3. Serum ...

6. High blood protein Causes - Mayo Clinic

   A total protein test may be done. Other, more-specific tests, including serum protein electrophoresis (SPEP), can help find the exact source, such as the liver ...

7. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Hemoglobin A1c ≥10%;; Fasting TGs > 500 mg/dL;; Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 according to the Modification of Diet in ...

8. Primary immunodeficiency - Symptoms & causes - Mayo Clinic

   Frequent infections could mean that you have an immune system disorder. The conditions in this category are usually caused by genetic changes.

9. A Study of the Efficacy and Safety of Belimumab Compared to Placebo in Adults With Systemic Sclerosis Associated Interstitial Lung Disease - Mayo Clinic

   mixed connective tissue disease, as determined by the investigator. 3. FVC ≤45% of predicted, or a DLco (corrected for hemoglobin) ≤40% of predicted or

10. Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

    Hemoglobin (HgB) >= 9.0 g/dL; Total bilirubin =< 1.5 x upper normal limit (UNL); Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase ...